Recombinant VEGF (Bevacizumab Biosimilar) antibody

Catalog No. ABIN5668150

Product Details anti-VEGF (Bevacizumab Biosimilar) Antibody

Target: VEGF (Bevacizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This VEGF (Bevacizumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), ELISA, Western Blotting (WB), Blocking Reagent (BR), Immunoprecipitation (IP)

Specificity: This antibody binds native and reduced human VEGF (isoform 165).

Characteristics:

OriginalSpeciesName: Human

OriginalFormat: IgG1

Purification: Purified antibody.

Purity: > 98 % as determined by SDS-PAGE

Endotoxin Level: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogen: Recombinant human VEGF.

Isotype: IgG1 kappa

Application Details

Application Notes: This is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.

Comment:

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Restrictions: For Research Use only

Handling

Buffer: PBS with 0.02 % Proclin 300.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Target Details for VEGF (Bevacizumab Biosimilar)

Target: VEGF (Bevacizumab Biosimilar)

Abstract: VEGF (Bevacizumab Biosimilar) Products

Synonyms: MVCD1 antibody, VEGF antibody, VPF antibody, vascular endothelial growth factor A antibody, VEGFA antibody

Background: Ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF

UniProt: P15692